Román G C
Medicine/Neurology, University of Texas Health Science Center at San Antonio, TX 78229-3900, USA.
Acta Neurol Scand Suppl. 2002;178:6-9.
The recognition of cerebrovascular disease (CVD) as a contributing factor and a cause of dementia has led to the development of clinical criteria for vascular dementia (VaD). Due to high specificity, the consensus criteria developed by the National Institute for Neurological and Communicative Disorders and Stroke (NINDS)-Association Internationale pour la Recherche et l'Enseignement en Neurosciences (AIREN) have been used in controlled clinical trials to select patients with pure VaD. VaD is predominantly a subcortical frontal form of dementia with prominent executive dysfunction. In contrast, the criteria of the NINCDS-Alzheimer's Disease and Related Disorders Association (ADRDA) emphasize memory loss as the main feature to distinguish Alzheimer's disease (AD) from VaD and from other forms of dementia. Moreover, CVD may precipitate the clinical expression of AD. Although no criteria have been created specifically for patients having AD with CVD, the ischemic score, the Informant Questionnaire on Cognitive Decline in the Elderly and a history of prestroke mild cognitive impairment (MCI) may be useful for identifying patients with this mixed form of dementia.
脑血管疾病(CVD)被认为是痴呆症的一个促成因素和病因,这促使了血管性痴呆(VaD)临床标准的制定。由于具有高特异性,美国国立神经疾病与中风研究所(NINDS)-国际神经科学研究与教育协会(AIREN)制定的共识标准已用于对照临床试验,以挑选出纯VaD患者。VaD主要是一种具有突出执行功能障碍的皮质下额叶型痴呆。相比之下,美国国立神经疾病与中风研究所-阿尔茨海默病及相关疾病协会(NINCDS-ADRDA)的标准强调记忆丧失是将阿尔茨海默病(AD)与VaD及其他形式痴呆区分开来的主要特征。此外,CVD可能促使AD的临床症状出现。虽然尚未专门为患有AD合并CVD的患者制定标准,但缺血评分、老年人认知衰退知情者问卷以及中风前轻度认知障碍(MCI)病史可能有助于识别这种混合型痴呆患者。